| Symposium 3A: Financial Sustainability of Biobanks |
| Brent Schacter and Peter Watson (Canada) - Sustainability of Canadian biorepositories: Status, needs and national initiatives |
| Rusty Bromley (USA) - Financial Stability in Biobanking Unique Challenges for Disease Focused Patient Advocacy Organizations |
| Brian Thomson (UK) |
| Peter Riegman (Netherlands) |
| |
| Symposium 3B: Model Organisms and Biodiverse Biorepositories: Interdisciplinary Perspectives in Biobanking |
| Harvey Blackburn (USA) - From Concept to Application: Developing a Functional DNA and Germplasm Repository for Animal Genetic Resources |
| Rebecca Spindler (Australia) - The Ins and Outs of a Living Bank: Prioritisation, Viable Populations and Continual Access |
| Paul Bartels (South Africa) - Keeping Clear of the Lion's Mouth - Establishing & Scaling-up a Biodiversity Biobank for Southern Africa |
| Rebecca Pugh (USA) - The International Environmental Specimen Bank (IESB) Group |
| Erin Ehmke (USA) - The Endangered Species Challenge: Making Use of Opportunistic Sampling |
| |
| Innovative Technologies |
| Pasquale De Blasio (USA) - Tissue Microarray Technology: New Opportunity for Tissue Banks to Contribute to Cancer Research and Diagnostics |
| Beate Kamlage (Germany) - New Metabolic Assay for Pre-Analytical Quality Control of Human Plasma Samples |
| Marie Lee (USA) - The Fluidigmn SNPtrace Panel and the BioMark System Enable Fast, Efficient, and Cost-Effective Sample Assessment with Minimal Hands-On Time |
| Alexander Werner (Germany) - Technologies to Fully Automate Biological Vapor-Phase Nitrogen Repositories Below -100 ºC |
| Charlotta Göransson (Sweden) - Rapid Heat Stabilization of Enzymes is Essential for Accurate Measurement of Tissue Sample Analytes without Interference from Post-Mortem Events |
| |
| Contributed Paper Session 1: Specimen Quality: Do you Know What you are Really Working With? |
Anita Posevitz-Fejfár (Germany) - The Effect of Blood Shipping on the Survival and Functionality of PBMCs
|
Vinagolu Rajasekhar (USA) - Developing Mouse Hospital with Human Patient Derived Xenograft Cancer Models – A Live Tumor Banking Approach
|
Xianling Cong (China) - Biobanking of Human Kidney Cancer Tissue: Impact of Ex-Vivo Ischemia Time and Storage Time on RNA Quality
|
Michael Roehrl (Canada) - Next Generation BioSpecimen Sciences at University Health Network – Canada’s Largest Hospital-Based Research Program
|
Galen Hostetter (USA) - Tissue Modeling of RNA Degradation: Multi-Modality Measures and Biological Pathway Correlates
|
Olga Kofanova (Luxembourg) - Gene Expression Assay to Assess the Pre-Centrifugation Delay of PBMCs
|
Yinan Zhang (China) - Storage Stability of Metabolic Diseases Biomarkers in Urine
|
| |
| Contributed Paper Session 2: ELSI for Biobanking - Is the Tail Wagging the Dog? |
Maui Hudson (New Zealand) - Developing Best Practice Biobanking with Indigenous Peoples
|
Katheryn Shea (USA) - Future Use Considerations for Global Collections of Human Biospecimens: Annotation to Ensure Compliance in an Evolving Global Regulatory Environment
|
Rachel Dvoskin (USA) - Senior Biobank Staff and Genetic Researchers’ Opinions about Human Subjects Practices in Genomic Research
|
Evert-Ben van Veen (The Netherlands) - EU Data Protection Regulation and Transatlantic Datasharing
|
Janet Olson (USA) - Genetic Knowledge and Return of Results Preferences in the Mayo Clinic Biobank
|
| Rania Labib (Egypt) - Omics-Ready Bio/Data Repository For Childhood Cancers in Egypt |
Erin Winkler (USA) - Role of the Genetic Counselor in a Non-Disease Focused Biobank: Experience of the Mayo Clinic Biobank
|
Print Page
